alergi lia

Upload: lia-restimulia-delfitri

Post on 01-Jun-2018

244 views

Category:

Documents


0 download

TRANSCRIPT

  • 8/9/2019 Alergi Lia

    1/23

    ALLERGY: PATHOPHYSIOLOGYLia Restimulia

     

  • 8/9/2019 Alergi Lia

    2/23

  • 8/9/2019 Alergi Lia

    3/23

     

    Hypersensitivity (hypersensitivityreaction) refers to undesirable immunereactions produced by the normal immune

    system.

    Hypersensitivity reactions: four types; based on the mechanisms involved andtime taen for the reaction, a particularclinical condition (disease) may involvemore than one type of reaction.

    Hypersensitiv

    ity

  • 8/9/2019 Alergi Lia

    4/23

    Classification of Immunologic Reactions

    (Gel and Coombs) 

  • 8/9/2019 Alergi Lia

    5/23

    Allergy

    Ig E mediated

    (Type Ihypersensitivity)

    Non Ig Emediated

    Allergy

  • 8/9/2019 Alergi Lia

    6/23

     

    !verreaction to an allergen ( antigen thatcauses allergy) after fe" minutes contact

    through sin, inhaled through lung,

    s"allo"ed or in#ected. Triggered by harmless substances such as;

     pollen, dust, animal danders, food, drug or

     bee stings or stings from other insects

    IgE Mediated:Type I hypersensitivity

  • 8/9/2019 Alergi Lia

    7/23

     

    Atopy is the genetic predisposition to mae $gE antibodies in responseto allergen e%posure.

    Etiology is unno"n

    Primary Atopic Conditions

    Alleric r!initis "AR) Sinusitis

    Atopic ec#ema "AE)

    Alleric ast!ma "AA)

    Allergic gastroenteropathy is rare.

    These manifestation may coe%ist in the same patients at different times.

    Atopy can be asymptomatic.

    Atopy

  • 8/9/2019 Alergi Lia

    8/23

     Genes Identifed to date in

    Atopy

  • 8/9/2019 Alergi Lia

    9/23

    Alleric R!initis "RA)Alleric R!initis "RA)

    A$normalities o% t!e nose due tonasal mucosal in&ammatoryprocess

    'ediated $y type I !ypersensiti(itySymptoms : snee#in nasal

    itc!in r!inorr!ea and nasal

    conestionRe(ersi$le spontaneously or *it!

    treatment

  • 8/9/2019 Alergi Lia

    10/23

    RA classi+cationRA classi+cation

  • 8/9/2019 Alergi Lia

    11/23

    Proteins ,orein serum

    -accines

    Plant pollens Rye rass

    Ra*eed Timot!y rass

    .irc! trees

    /rus Penicillin

    Sul%onamides Local anet!etics

    Salicylates

    ,oods0uts

    Sea%ood

    Es

    Peas $eans

    'il1

    Insect products .ee (enom

    2asp (enom

    Ant (enom

    Coc1roac! caly3/ust mites

    'old spores Animal !air and dander

    &ommon allerens associated *it!type I !ypersensti(ity

  • 8/9/2019 Alergi Lia

    12/23

     

    'hile firsttime e%posure may only produce amild reaction, repeated e%posures may lead tomore serious reactions.

    !nce a person is sensitied (has had a previoussensitivity reaction), even a very limitede%posure to a very small amount of allergen cantrigger a severe reaction.

    *ost occur "ithin seconds or minutes aftere%posure to the allergen, but some can occurafter several hours, particularly if the allergencauses a reaction after it is partially digested. $n

    very rare cases, reactions develop after + hours.

    'ec!anism

  • 8/9/2019 Alergi Lia

    13/23

    ImmunopathogenesisImmunopathogenesis

    -oth mast cells and basophils are

    involved in immunopathogenesis of $gE

    mediated diseases.

    T and B cells play important roles in

    the development of these antibodies

  • 8/9/2019 Alergi Lia

    14/23

    ImmunopathogenesisImmunopathogenesis

  • 8/9/2019 Alergi Lia

    15/23

    ImmunopathogenesisImmunopathogenesis

  • 8/9/2019 Alergi Lia

    16/23

    ImmunopathogenesisImmunopathogenesis

    *ast cell are abundant in the mucosa of therespiratory, gastrointestinal tracts and in the

    sin, "here atopic reaction localie.

    *ast cell release mediator cause the pathophysiology of the immediate and late

     phases of atopic diseases.

  • 8/9/2019 Alergi Lia

    17/23

    type I !ypersensti(itytype I !ypersensti(ity "early and late p!ase)"early and late p!ase)

  • 8/9/2019 Alergi Lia

    18/23

    Re4e3posureRe4e3posure

  • 8/9/2019 Alergi Lia

    19/23

    .road Alleric Cascade.road Alleric Cascade

    4'ediators4'ediators

    IL = Interleukin TN!"a= Tumor ne#rosis $a#tor"alpha%ANTE& = %egulated on a#tivation' normal T #ellepressed and se#reted )*AM = )as#ular #elladhesion mole#ule I*AM"+ = Inter#ellular adhesion

    mole#ule"+,

  • 8/9/2019 Alergi Lia

    20/23

    Important Clinical Aspects of ImmediateImportant Clinical Aspects of Immediate

    HypersensitivityHypersensitivity

    Main organ -isease Mainsymptoms

    Typi#alallergens

    %oute o$entery

    Lun Ast!ma 2!ee#indyspnea

    tac!ypnea

    Pollens !ousedust animal

    danders

    In!alation

    0ose andEyes

    R!initiscon5uncti(itis

    Hay %e(er

    Runny noseredness and

    itc!in o%eyes

    Pollens Contact *it!mucous

    mem$rane

    S1in Ec#ema "atopicdermatitis)6rticaria

    Pruritic(esicularlesions

    Pruritic$ullouslesions

    6ncertain-arious %oods

    /rus

    6ncertainInestion-arious

    Intestinaltract

    Allericastroenteropat!y

    -omitindiarr!ea

    -arious %ood Inestion

    Systemic Anap!yla3is S!oc1!ypotension

    Insect(enom7$ee

    Stin-arious

  • 8/9/2019 Alergi Lia

    21/23

    Hypersensitivity pneumonitis involves inhalationof an antigen. This leads to an

    e%aggerated immune response(hypersensitivity). Type $$$ hypersensitivity

    and type $ hypersensitivity occur in

    hypersensitivity pneumonitis. 

    Allergic contact dermatitis.

    Allergi# Hypersensitivity. Non IgE

    Mediated

  • 8/9/2019 Alergi Lia

    22/23

     

    Res!lt Antigen so!rce "echanism #isease

    /isease 0oreign $mmunologic Allergy

    1rophyla%is 0oreign $mmunologic $mmunity

    /isease 2elf $mmunologic Autoimmunity

    /isease 0oreign To%ic To%icity

    *omparison o$ Allergy /ith other %esponses

  • 8/9/2019 Alergi Lia

    23/23